HP
AVEO

Hikari Power’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Hikari Power’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8,000
Closed -$66K – 150
2019
Q1 		$66K Hold
8,000
– – 0.01% 121
2018
Q4 		$128K Buy
+8,000
New +$176K 0.01% 122

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Hikari Power's AVEO Position: Q2 2019 in Review

Hikari Power sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2019, closing a stake of 8,000 shares — an estimated $66K sold.

Hikari Power first reported a position in AVEO in Q4 2018 and held it in 2 quarters. The position peaked at $128K in Q4 2018. 73 funds tracked by Wall St. Rank hold AVEO as of Q2 2019.

  • Hikari Power reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Hikari Power sold 8,000 AVEO Pharmaceuticals, Inc. shares in Q2 2019, an estimated $66K.
  • Hikari Power first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2018 and held it in 2 quarters.
  • Hikari Power's AVEO Pharmaceuticals, Inc. position peaked at $128K in Q4 2018.
  • 73 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2019.

Based on Hikari Power's 13F filing for Q2 2019, filed 8 Aug 2019.